Treatment of 1-methyl-1-nitrosourea-induced mammary tumours with immunostimulatory CpG motifs and 13-cis retinoic acid in female rats: Histopathological study

Experimental and Toxicologic Pathology

Volumn 55, Issue 2-3, 2003, Pages 173-179

  Liska, Jan ^a,b   Macejova, Danica ^b   Galbavy, Stefan ^a   Baranova, Maria ^b   Zlatos, Jozef ^a   Stvrtina, Svetoslav ^a   Mostbock, Sven ^a,c   Weiss, Richard ^c   Scheiblhofer, Sandra ^c   Thalhamer, Joseph ^c   Brtko, Julius ^b  

^a Faculty of Natural Sciences   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c UNIVERSITY OF SALZBURG   (Austria)

Author keywords

1 Methyl 1 nitrosourea; 13 Cis retinoic acid; CpG motifs; Experimental carcinogenesis; Histopathology; Mammary tumour; Sprague Dawley rat

Indexed keywords

CPG DEOXYNUCLEOTIDE; ISOTRETINOIN; METHYLNITROSOUREA; OLIGODEOXYNUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; CPG ISLAND; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNOSTIMULATION; NONHUMAN; PROTEIN MOTIF; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALIA;

EID: 10744219936     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00308     Document Type: Article

References (15)

1. ANZANO MA, BYERS SW, SMITH JM, et al.: Prevention of breast cancer with 9-cis retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 1994; 54: 4614-7.
2. BRTKO J, HARTL A, SCHEIBLHOFER S, et al.: DNA immunization in vivo down-regulates nuclear all-trans retinoic acid receptors in mouse spleen cells. Mol Cell Endocrinol 2000; 165: 107-113.
3. GOMORI, G: Silver Impregnation of Reticulum in Paraffin Sections. Am J Path 1937; 13: 993-1002.
4. GULLINO PM, PETTIGREW HM, GRANTHAM, FH: N-nitro-somethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 1975; 54: 401-409.
5. LACROIX A, DOSKAS C, BHAT PV: Inhibition of established N-methyl-N-nitrosourea-induced cancer in rats by retinoic acid and ovariectomy. Cancer Res 1990; 50: 5731-5734.
6. LISKA J, GALBAVY S, MACEJOVA D, et al.: Histopathology of mammary tumours in female Sprague-Dawley rats treated with 1-methyl-1-nitrosourea. Endocr Regul 2000; 34: 91-96.
7. MACEJOVA D, DVORCAKOVA M, WEISS R, et al.: Reduction of 1-methyl-1-nitrosourea induced Mammary Gland Carcinoma by in vivo Application of Immunostimulatory CpG Motifs in Sprague-Dawley Rats. Gen Physiol Biophys 2001; 20: 445-448.
8. MACEJOVA D, LISKA J, BRTKO J: Mammary Gland Carcinoma-related Increase of Type I Iodothyronine 5′-deiodinase Activity in Sprague-Dawley Rats. Gen Physiol Biophys 2001; 20: 293-302.
9. MACEJOVA D, LISKA J, DVORCAKOVA M, et al.: Status of nuclear retinoic acid receptors in MNU-induced mammary gland tumours in Sprague-Dawley Rats. Structure and Stability of Biomacromolecules SSB'01, Kosice 2001; 35-36.
10. MCCORMICK DL, ADAMOWSKI CB, FIKS A, et al.: Lifetime dose response relationships for mammary tumour induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 1981; 41: 1690-1694.
11. MOON RC, CONSTANTINOU AI: Dietary retinoids and carotenoids in rodent models of mammary carcinogenesis. Breast Cancer Res Treat 1997; 46: 181-189.
12. RUSSO J, RUSSO IH, ROGERS AE, et al.: Tumours of mammary gland. In: TURUSOV V, MOHR U (Eds). Pathology of tumours in laboratory animals. Vol. 1, Tumours of the rat. IARC Scientific Publications, Lyon 1990; 47-78.
13. SUN S, ZHANG X, TOUGH DF, et al.: Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998; 188: 2335-2342.
14. THOMPSON HJ, MCGINLEY JN, ROTHHAMMER K, et al.: Rapid induction of mammary intraductal proliferation, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 1995; 16: 2407-2411.
15. WELSCH CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985; 45: 3415-3443.